Urinary Incontinence News and Research

RSS
Urinary incontinence (UI), or the unintentional loss of urine, is a problem for more than 13 million Americans—85 percent of them women. Although about half of the elderly have episodes of incontinence, bladder problems are not a natural consequence of aging, and they are not exclusively a problem of the elderly.

Incontinence has several causes. Women are most likely to develop incontinence either during pregnancy and childbirth, or after the hormonal changes of menopause, because of weakened pelvic muscles. Older men can become incontinent as the result of prostate surgery. Pelvic trauma, spinal cord damage, caffeine, or medications including cold or over-the-counter diet tablets also can cause episodes of incontinence.

But even though urinary incontinence can be improved in 8 out of 10 cases, fewer than half of those with bladder problems ever discuss the condition with their health care professional. The condition often goes untreated.
Insurance payers extend coverage for PTNS using Uroplasty's Urgent PC Neuromodulation System for OAB

Insurance payers extend coverage for PTNS using Uroplasty's Urgent PC Neuromodulation System for OAB

Genetic factors can explain people's susceptibility to urinary incontinence

Genetic factors can explain people's susceptibility to urinary incontinence

Prostatic artery embolization comparable to transurethral resection

Prostatic artery embolization comparable to transurethral resection

Uterine fibroid embolization reduces fibroid-related urinary symptoms

Uterine fibroid embolization reduces fibroid-related urinary symptoms

NeoTract initiates patient enrollment for UroLift System trial to treat prostrate cancer

NeoTract initiates patient enrollment for UroLift System trial to treat prostrate cancer

Astellas announces positive results from mirabegron phase III trials against OAB

Astellas announces positive results from mirabegron phase III trials against OAB

Positive results from TheraVida THVD-201 Phase 1 trial in patients with OAB, UUI

Positive results from TheraVida THVD-201 Phase 1 trial in patients with OAB, UUI

NAFC honors Florida's Cleveland Clinic physician with Continence Care Champion Award

NAFC honors Florida's Cleveland Clinic physician with Continence Care Champion Award

Study: Fluorescent probe may serve as useful tool in future surgeries to repair injured nerves

Study: Fluorescent probe may serve as useful tool in future surgeries to repair injured nerves

AMS introduces STEP toolkit to help men with ED and SUI

AMS introduces STEP toolkit to help men with ED and SUI

Insufficient evidence of interstitial brachytherapy's advantages for localized prostate cancer treatment

Insufficient evidence of interstitial brachytherapy's advantages for localized prostate cancer treatment

Negative aspects of prostate cancer screening acceptable

Negative aspects of prostate cancer screening acceptable

FemmePharma completes FP 1097 Phase II clinical trial in women with OAB

FemmePharma completes FP 1097 Phase II clinical trial in women with OAB

American Medical Systems fourth quarter sales increase 0.7% to $147.0 million

American Medical Systems fourth quarter sales increase 0.7% to $147.0 million

Pros and cons of weight loss surgery in men and women

Pros and cons of weight loss surgery in men and women

Antares Pharma submits NDA for Anturol Gel in patients with overactive bladder

Antares Pharma submits NDA for Anturol Gel in patients with overactive bladder

Halt Medical presents results of Halt Fibroid Study at NIH Global Fibroid Congress

Halt Medical presents results of Halt Fibroid Study at NIH Global Fibroid Congress

Preliminary results from Phase 1b/2a trial of MediciNova's ibudilast in opioid addicts announced

Preliminary results from Phase 1b/2a trial of MediciNova's ibudilast in opioid addicts announced

Emergent declares one-time cash dividend and regular dividend

Emergent declares one-time cash dividend and regular dividend

Palmetto GBA to cover PTNS therapy for patients with overactive bladder

Palmetto GBA to cover PTNS therapy for patients with overactive bladder